Innovative Medicines Initiative (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Innovative Medicines Initiative" in English language version.

refsWebsite

Global rank English rank

10nih.gov

4^th place

9doi.org

2^nd place

2semanticscholar.org

11^th place

8^th place

2web.archive.org

1^st place

1research-europe.com

low place

1imi-europe.org

low place

1europa.eu

68^th place

117^th place

1emtrain.eu

low place

doi.org

Hughes, V. (2008). "Europe pledges billions to solve its drug development woes". Nature Medicine. 14 (2): 107. doi:10.1038/nm0208-107. PMID 18256603.
Goldman, M. (2012). "The Innovative Medicines Initiative: A European Response to the Innovation Challenge". Clinical Pharmacology & Therapeutics. 91 (3): 418–425. doi:10.1038/clpt.2011.321. PMID 22318619. S2CID 11860265.
Frima, H. J.; Gabellieri, C.; Nilsson, M. I. (2012). "Drug delivery research in the European Union's Seventh Framework Programme for Research". Journal of Controlled Release. 161 (2): 409–415. doi:10.1016/j.jconrel.2012.01.044. PMID 22333557.
Goldman, M. (2011). "Reflections on the Innovative Medicines Initiative". Nature Reviews Drug Discovery. 10 (5): 321–322. doi:10.1038/nrd3434. PMID 21532547. S2CID 34263113.
Unbiased Biomarkers for the Prediction of Respiratory Disease Outcome (u-Biopred) Consortium; Bel, E. H.; Sousa, A.; Fleming, L.; Bush, A.; Chung, K. F.; Versnel, J.; Wagener, A. H.; Wagers, S. S.; Sterk, P. J.; Compton, C. H. (2010). "Diagnosis and definition of severe refractory asthma: An international consensus statement from the Innovative Medicines Initiative (IMI)". Thorax. 66 (10): 910–917. doi:10.1136/thx.2010.153643. PMID 21106547.
Wilkinson, E. (2008). "Will the Innovative Medicines Initiative really deliver innovative medicines?". Molecular Oncology. 2 (3): 203–205. doi:10.1016/j.molonc.2008.07.007. PMC 5527805. PMID 19383340.
Kamel, N.; Compton, C.; Middelveld, R.; Higenbottam, T.; Dahlen, S. E. (2008). "The Innovative Medicines Initiative (IMI): A new opportunity for scientific collaboration between academia and industry at the European level". European Respiratory Journal. 31 (5): 924–926. doi:10.1183/09031936.00033208. PMID 18448501.
Halban, P. A. (2007). "The Innovative Medicines Initiative (IMI): A shot in the arm for European diabetes research?". Diabetologia. 50 (9): 1791–1794. doi:10.1007/s00125-007-0740-y. PMID 17611733.
Sinha, G. (2011). "Spat over Innovative Medicines Initiative (IMI) funding and intellectual property". Nature Biotechnology. 29 (6): 473. doi:10.1038/nbt0611-473a. PMID 21654659.

emtrain.eu

launch announcement September 2014 (Press Release)

europa.eu

imi.europa.eu

Factsheets for IMI projects, IMI, 2011, retrieved 17 August 2011.

imi-europe.org

Reference on EFPIA's IMI site Archived 6 August 2008 at the Wayback Machine

nih.gov

pubmed.ncbi.nlm.nih.gov

Hughes, V. (2008). "Europe pledges billions to solve its drug development woes". Nature Medicine. 14 (2): 107. doi:10.1038/nm0208-107. PMID 18256603.
Goldman, M. (2012). "The Innovative Medicines Initiative: A European Response to the Innovation Challenge". Clinical Pharmacology & Therapeutics. 91 (3): 418–425. doi:10.1038/clpt.2011.321. PMID 22318619. S2CID 11860265.
Frima, H. J.; Gabellieri, C.; Nilsson, M. I. (2012). "Drug delivery research in the European Union's Seventh Framework Programme for Research". Journal of Controlled Release. 161 (2): 409–415. doi:10.1016/j.jconrel.2012.01.044. PMID 22333557.
Goldman, M. (2011). "Reflections on the Innovative Medicines Initiative". Nature Reviews Drug Discovery. 10 (5): 321–322. doi:10.1038/nrd3434. PMID 21532547. S2CID 34263113.
Unbiased Biomarkers for the Prediction of Respiratory Disease Outcome (u-Biopred) Consortium; Bel, E. H.; Sousa, A.; Fleming, L.; Bush, A.; Chung, K. F.; Versnel, J.; Wagener, A. H.; Wagers, S. S.; Sterk, P. J.; Compton, C. H. (2010). "Diagnosis and definition of severe refractory asthma: An international consensus statement from the Innovative Medicines Initiative (IMI)". Thorax. 66 (10): 910–917. doi:10.1136/thx.2010.153643. PMID 21106547.
Wilkinson, E. (2008). "Will the Innovative Medicines Initiative really deliver innovative medicines?". Molecular Oncology. 2 (3): 203–205. doi:10.1016/j.molonc.2008.07.007. PMC 5527805. PMID 19383340.
Kamel, N.; Compton, C.; Middelveld, R.; Higenbottam, T.; Dahlen, S. E. (2008). "The Innovative Medicines Initiative (IMI): A new opportunity for scientific collaboration between academia and industry at the European level". European Respiratory Journal. 31 (5): 924–926. doi:10.1183/09031936.00033208. PMID 18448501.
Halban, P. A. (2007). "The Innovative Medicines Initiative (IMI): A shot in the arm for European diabetes research?". Diabetologia. 50 (9): 1791–1794. doi:10.1007/s00125-007-0740-y. PMID 17611733.
Sinha, G. (2011). "Spat over Innovative Medicines Initiative (IMI) funding and intellectual property". Nature Biotechnology. 29 (6): 473. doi:10.1038/nbt0611-473a. PMID 21654659.

ncbi.nlm.nih.gov

Wilkinson, E. (2008). "Will the Innovative Medicines Initiative really deliver innovative medicines?". Molecular Oncology. 2 (3): 203–205. doi:10.1016/j.molonc.2008.07.007. PMC 5527805. PMID 19383340.

research-europe.com

"Professor Michel Goldman, Innovative Medicines Initiative". research-europe.com. Archived from the original on 20 May 2015. Retrieved 1 June 2015.

semanticscholar.org

api.semanticscholar.org

Goldman, M. (2012). "The Innovative Medicines Initiative: A European Response to the Innovation Challenge". Clinical Pharmacology & Therapeutics. 91 (3): 418–425. doi:10.1038/clpt.2011.321. PMID 22318619. S2CID 11860265.
Goldman, M. (2011). "Reflections on the Innovative Medicines Initiative". Nature Reviews Drug Discovery. 10 (5): 321–322. doi:10.1038/nrd3434. PMID 21532547. S2CID 34263113.

web.archive.org

"Professor Michel Goldman, Innovative Medicines Initiative". research-europe.com. Archived from the original on 20 May 2015. Retrieved 1 June 2015.
Reference on EFPIA's IMI site Archived 6 August 2008 at the Wayback Machine